Robins Roadshow Special Situations Conference
May 4th, 2004
8:00AM ET - 4:00PM ET


8:00 Registration & Continental Breakfast
  Ballroom Library
9:00 Hooper Holmes (HH) Matrixx Initiatives (MTXX)
9:45 Taser International (TASR) TBA
10:30 Barrett Business Services (BBSI) Supergen Inc. (SUPG)
11:15 Cascade Corporation (CAE) Psychemedics (PMD)
12:00 Lunch - Marc Robins’ Keynote Address: Shifting Small-Cap Tides
1:00 Quiet Tiger (QTIG.OB) ComCam, Inc. (CMCA.OB)
1:45 Metron Technology (MTCH) Excel Technology (XLTC)
2:30 Firstwave (FSTW) TBA
3:15 TBA TBA


**For more information or to register to attend this event,**
**Please contact Priscilla Warren at Catalyst Financial Resources, 503-241-1880**


 

 
 
 

It's the Closest Thing
to Alchemy an
Investor Can Get


To register to attend this conference, click here
or call 503- 445-2490.


Amazing But True

Since the mythology of medieval times, a belief in the process of using earth's elements to turn base metals into gold has faded into that foggy realm of superstition. But the idea of creating a process for turning raw materials into gold still lives in the hearts of the American Entrepreneur. The innovators, the CEOs, the CFOs- today's Alchemists. They work with a different set of elements. They know, that technology stirred by imagination creates invention, that the right place combined with the right time creates opportunity, that with all these things and a lot of hard work you can create a successful small-cap company. And if they're either really lucky or they've been managed by sheer genius, the clouds rumble, the lightning flashes, and they are rewarded with a Special Situation. What is even more amazing is that, although America's Small-cap companies represent the majority of the GDP and GDP growth in America and are responsible for not only the majority of workers employed in the U.S.A, but also the growth of that employment, the investment community is all but unaware of most of them. Incredibly, Wall Street has virtually ignored these young, vibrant, and promising companies. Roughly 44% of Nasdaq's listings (approximately 3,800 companies) have no analyst coverage at all, with an additional 14% of these listings covered by just one analyst. We believe the absence of equity research results in undervalued stocks. In fact, studies since October of 1997 have shown that those stocks that have lost analyst coverage have substantially under-performed the S&P 500 by nearly two percentage points. Our goal is to improve awareness of deserving companies by heightening an understanding of their outlook or value. Investors of all types stand to benefit from the robust coverage of America's most promising stock sector.